Achim Kaufhold
Chief Tech/Sci/R&D Officer at HANSA BIOPHARMA AB
Profile
Achim Kaufhold is currently working as a Director at Anzamune Ltd., an Independent Director at Biosergen AB, a Professor at RWTH Aachen University, and as the Chief Medical Officer & Senior Vice President at Hansa Biopharma AB.
Previously, he worked as the President & CEO at Affitech A, Chairman at CMP Therapeutics Ltd., Director-Clinical Development at GSK Plc, Director-Executive Board at Pevion Biotech AG, Independent Director at Vaximm AG, Chief Medical Officer & Vice President at Chiron Corp., Chief Medical Officer at Berna Biotech AG, Chief Scientific & Medical Officer at Pharmexa A, and Chief Medical Officer at Basilea Pharmaceutica AG.
He holds a doctorate degree from Universität zu Köln.
Achim Kaufhold active positions
| Companies | Position | Start |
|---|---|---|
| HANSA BIOPHARMA AB | Chief Tech/Sci/R&D Officer | 01/06/2020 |
| BIOSERGEN AB | Director/Board Member | 01/01/2021 |
| RWTH Aachen University | Corporate Officer/Principal | 29/12/2009 |
Anzamune Ltd.
 Anzamune Ltd. Pharmaceuticals: MajorHealth Technology Anzamune Ltd. develops therapeutic drugs. It also develops drugs for allergic disorders. Its products are based on chitin, a natural product found widely in shellfish and insect shells. The company was founded on June 6, 2007 and is headquartered in Ashhurst, New Zealand. | Director/Board Member | 07/08/2007 |
Former positions of Achim Kaufhold
| Companies | Position | End |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Chief Tech/Sci/R&D Officer | 01/12/2017 |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Director/Board Member | 01/02/2016 |
Pharmexa A/S
 Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Chief Executive Officer | 16/06/2009 |
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Chief Executive Officer | 01/01/2009 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Chief Tech/Sci/R&D Officer | 01/01/2006 |
Training of Achim Kaufhold
| Universität zu Köln | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GSK PLC | Health Technology |
| BASILEA PHARMACEUTICA AG | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| BIOSERGEN AB | Health Technology |
| Private companies | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Berna Biotech AG produced and developed immunobiological preparations. It offered respiratory, hepatitis B, pediatric, veterinary and travel vaccines. The company was founded in 1898 and was headquartered in Bern, Switzerland | Commercial Services |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
Pevion Biotech AG
 Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Pevion Biotech AG develops efficient and safe vaccines based on proprietary technology. The firm provides preclinical and clinical development of prophylactic/therapeutic vaccines based on its virosome-based technology platform. The company was founded in 2002 and is headquartered in Ittigen, Switzerland. | Health Technology |
Anzamune Ltd.
Anzamune Ltd. Pharmaceuticals: MajorHealth Technology Anzamune Ltd. develops therapeutic drugs. It also develops drugs for allergic disorders. Its products are based on chitin, a natural product found widely in shellfish and insect shells. The company was founded on June 6, 2007 and is headquartered in Ashhurst, New Zealand. | Health Technology |
CMP Therapeutics Ltd.
 CMP Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology CMP Therapeutics Ltd. developed products for colds, flu, and allergy. It offered nasal spray for allergic rhinitis; and anti-infective nasal spray for preventing influenza and colds. The company was founded in 2004 and was headquartered in Oxford, the United Kingdom. | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Stock Market
- Insiders
- Achim Kaufhold
